Why the study?
The morphological characteristics of CAD and long-term cardiovascular outcomes in patients with concurrent systemic sclerosis and CAD remained unclear.
Does the presence of systemic sclerosis worsen long-term cardiovascular outcomes in patients with CAD undergoing percutaneous coronary intervention?
Does the presence of systemic sclerosis worsen long-term cardiovascular outcomes in patients with CAD undergoing percutaneous coronary intervention?
Systemic sclerosis is associated with more complex coronary artery disease and poorer long-term cardiovascular outcomes following percutaneous coronary intervention.
No takes yet. Share an insight, caveat, or question.
SSc may warrant closer post-PCI surveillance in CAD; leaves open whether targeted strategies improve outcomes.
Hirose et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: